TinyGemsBreaks Archive - Page 124 of 130

MondayJun 27, 2022 1:46 pm

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Moving Forward with Phase 1/2a Clinical Trial after Receiving Key FDA Approval

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has received approval from the U.S. Food and Drug Administration (“FDA”) to proceed with its phase 1/2a first-in-human clinical trial evaluating CYB003; the company has received a “may proceed” letter and investigational new drug application (“IND”) clearance from the FDA. The approval means that CYB003 will be the first novel psilocybin analog to enter clinical development, with patient recruitment beginning immediately and pharmacokinetic and safety data readout anticipated by fourth quarter 2022. According to the announcement, Cybin’s CYB003 is a proprietary deuterated psilocybin analog being developed for…

FridayJun 24, 2022 12:23 pm

TinyGemsBreaks – GreenBox POS (NASDAQ: GBOX) Becomes Among Sector’s 1st to Ensure Real-Time Custodial Account Attestations

GreenBox (NASDAQ: GBOX) is a financial technology company that leverages proprietary blockchain security and token technology to deliver customized payment solutions. The company has consistently called for improved processes to make the stablecoin industry custodial and transactional — the two elements GreenBox believes are critical to the industry’s long-term success. Upon completing a rigorous process, GreenBox has announced a partnership with accounting and consulting firm Armanino to attest to all GreenBox custodial accounts in real-time. “I could not be more pleased to see the stablecoin industry and the regulators move in the direction GreenBox has built our company on since…

ThursdayJun 23, 2022 4:33 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures FDA Approval for Protocol Amendment to Ongoing Potentially Pivotal Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced its receipt of approval from the U.S. Food and Drug Administration (“FDA”) for its ongoing potentially pivotal global study evaluating the efficacy and safety of Berubicin compared with Lomustine (Gleostine) administered after first line therapy for the treatment of recurrent glioblastoma multiforme (“GBM”), one of the most aggressive types of brain cancer. “We are pleased to have received this positive response from the FDA and to continue driving the…

ThursdayJun 23, 2022 3:11 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Shareholder Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today provided an update to its shareholders, including recent highlights and accomplishments for the company, the Mullen FIVE and the Mullen EV Van programs. Among the various highlights, the company reported that its solid-state polymer battery cell was successfully tested for the second time at Battery Innovation Center (“BIC”) in Indiana. The follow-up testing through an accredited facility shows promise for solid-state polymer cell technology when scaled to the vehicle pack level and used in EVs. “2022 has been an exceptional year for us so far; I am very proud…

WednesdayJun 22, 2022 3:08 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Files 130+ US, International Patent Applications for Mullen FIVE EV Crossover

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has filed over 130 patents in 24 countries in support of the Mullen FIVE EV Crossover program. Per the update, the 130-plus patent applications relate to Mullen FIVE EV’s design and styling of its exterior and interior. They include areas such as vehicle bodywork, headlights and taillights, doors, mirrors, rims, headliners, seats and steering. “We fully intend to make the Mullen FIVE available around the world, and these patents, including filings in 24 international countries, show our intended commitment to do so,” said David Michery, CEO…

WednesdayJun 22, 2022 2:48 pm

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Business Highlights, FY 2022 Results

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today reported recent business highlights and audited financial results for its fiscal year ended March 31, 2022. In addition, the company reiterated its anticipated pipeline and strategic milestones for the remainder of 2022. “Cybin made important progress across the board in recent months, accelerating both our pipeline of proprietary investigational psychedelic-based treatments and strategic partnership programs. Our successful preclinical work has set the foundation for a seamless transition to in-human trials,” said Cybin CEO Doug Drysdale. “Over a very short time horizon, we have evolved…

WednesdayJun 22, 2022 2:30 pm

TinyGemsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Acquisition News Featured in NNA Broadcast

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, is featured in a recent NetworkNewsAudio (“NNA”) broadcast. The focus of the audio broadcast is the company’s recent decision to acquire a 50% interest in a portfolio of RNG development projects through a definitive agreement with Northeast Renewables LP. According to the announcement, EverGen will acquire a 50% interest in Project Radius, a late-development-stage portfolio of three high-quality, on-farm RNG projects located in southern Ontario. The company anticipates that the three projects are capable of producing an estimated 1.7 million GJ/year of RNG, which will contribute to the…

TuesdayJun 21, 2022 3:10 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Enters Strategic Manufacturing, License Agreements with BevNology

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the signing of two agreements with Atlanta-based BevNology LLC. According to the update, the first manufacturing operating agreement expands production capabilities for Lexaria’s own growing list of business-to-business (“B2B”) clientele interested in purchasing DehydraTECH-powered active ingredients for consumer packaged-goods brands. A new, state-of-the-art processing facility custom-built by BevNology is operational that increases and broadens production capacity and is currently serving Lexaria’s corporate clients. The second commercial license agreement empowers BevNology to offer DehydraTECH products with active ingredients derived from hemp including cannabidiol (“CBD”) under BevNology and…

TuesdayJun 21, 2022 2:32 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Extension of Senior Secured Convertible Note

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has extended the maturity of a senior secured convertible note of $28 million, originally due in July 2022, by two years. According to the update, the company originally entered into a secured convertible promissory note on July 23, 2020, with DBI Lease Buyback Servicing LLC, an affiliate of Drawbridge Investments LLC. An existing Mullen shareholder, Esousa Holdings LLC, has acquired the note from Drawbridge and entered into an agreement with Mullen to extend the note’s maturity date. Originally scheduled to mature on July 28, 2022, the…

TuesdayJun 21, 2022 1:42 pm

TinyGemsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Featured in Latest Episode of Bell2Bell Podcast

Golden Matrix Group (NASDAQ: GMGI), a gaming technology company, was featured in the Bell2Bell Podcast, a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. GMGI’s CEO Brian Goodman joined the latest episode to discuss Golden Matrix’s business model, which includes both business-to-business (“B2B”) and business-to-consumer (“B2C”) operations. “Our core business is B2B. We build gaming systems and provide gaming content to licensed online gaming operators,” Goodman said. “We do this in a number of ways. We can either provide the modules – marketing modules, customer retention, customer acquisition – or we can provide…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks